The National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health, today announced the launch of the ?Be The Generation? public awareness campaign, challenging young Americans to be the generation that ends AIDS through the discovery of a safe and effective preventive HIV vaccine.
Heavy alcohol consumption is strongly and consistently associated with sexual risk behaviors in both men and women in Botswana, according to one of the few research studies on the topic in sub-Saharan Africa.
Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that the results of a Phase 1 clinical trial of HGS004 (CCR5 mAb) demonstrate that it was well tolerated and exhibited antiviral activity in patients who are infected with HIV-1, the retrovirus that causes acquired immunodeficiency syndrome (AIDS). The results were reported in San Francisco in an oral presentation at the American Society for Microbiology’s 46th Annual Conference on Antimicrobial Agents and Chemotherapy (ICAAC).
Only one in five people with HIV in poor and middle-income countries receives the drugs that treat the virus, said a report by the U.S. Centers for Disease Control and Prevention on Thursday.
The Food and Drug Administration (FDA) today announced the tentative approval of generic abacavir (a-BAK-a-veer) sulfate tablets manufactured by Aurobindo Pharma LTD. of Hyderabad, India. Abacavir sulfate tablets are the first generic version of the already approved Ziagen Tablets, an anti-HIV medication manufactured by GlaxoSmithKline. This product will now be available for consideration for purchase under the President’s Emergency Plan for AIDS Relief.
Who is informing the president on HIV and AIDS?
Acemannan, a component of aloe gel, has been shown in laboratory tests to have immune-stimulating and anti-viral activities.
The number of new HIV infections in four south Indian states home to most of India’s 5.1 million people with the virus, has fallen by more than a third, rare good news in the fight against AIDS, a study reported.
The Food and Drug Administration (FDA) announced the tentative approval of Stavudine (stav’ yoo deen) for Oral Solution, 1 mg/mL to be manufactured by Aurobindo Pharma LTD. of Hyderabad, India. This product is the first generic version of the already approved Zerit for oral solution manufactured by Bristol-Myers Squibb. This child-friendly product is indicated for use in pediatric patients with HIV, from birth through adolescence. This product will now be available for consideration for purchase under the President’s Emergency Plan for AIDS Relief (PEPFAR).
HIV-positive women diagnosed with genital herpes during pregnancy appear to be quite likely to pass HIV to their infants, according to a study conducted in New York City.